Prosiectau (2914)
Cardiff University Schools involved in this Project
Analysis of the inhibitory effects of nitric oxide and cGMP on gap junctional communication and the EDHF phenomenon (26.06.2006 - 25.06.2009)
Analysis of urinary microRNAs as biomarkers for acute kidney injury (02.03.2015 - 30.04.2021)
- Bowen, Timothy
Analysis of urinary microRNAs as biomarkers for acute kidney injury (06.07.2015 - 16.08.2015)
- Bowen, Timothy
Analytical modelling work to inform the development of palliative care (09.02.2011 - 08.07.2011)
An analysis of wild type human cytomegalovirus (01.12.2010 - 08.05.2014)
- Wilkinson, Gavin
An anonymised dataset containing questionnaire responses from an online questionnaire with eye care practitioners in Wales (01.01.2021 - 31.12.2021)
- Nollett, Claire
An evaluation of the new medical statement "fit note": Analysis of fit note and sick note data (01.09.2011 - 01.02.2013)
- Cohen, Deborah
A new biology of clinical outcome in immune-mediated disease (01.11.2019 - 31.10.2021)
- Wong, Susan
A new window into the immune response funding during Type 1 Diabetes (01.11.2017 - 31.05.2019)
- Tatovic, Danijela
An exploratory study of the ability of 18F-FDG PET to predict response to palliative chemotherapy in patients with poor-prognosis, recurrent/metastatic head and neck cancer (01.04.2015 - 31.12.2020)
- Chester, John
An extension protocol for MS patients who participated in Genzyme-sponsored studies of alumtuzumab (01.04.2012 - 31.05.2020)
- Robertson, Neil
Angiogenesis and anti-angiogenic approach in human cancer (01.10.2007 - 30.09.2011)
- Jiang, Wen
An independent evaluation of 'The Filter' (01.07.2014 - 31.03.2015)
- Grant, Aimee
An Innovative model system of cell invasion in TSC/LAM to uncover new drug targets and therapies (15.07.2019 - 15.06.2022)
- Dunlop, Elaine
An innovative model system of cell invasion in TSL/LAM to uncover new drug targets and therapies (15.07.2019 - 14.06.2022)
- Dunlop, Elaine
An innovative multidisciplinary patient-centric early detection care model (01.04.2008 - 31.12.2009)
An integrated approach to rheumatology project (23.11.2012 - 22.11.2013)
- Cohen, Deborah
An integrated target validation and drug discovery platform for the identification of novel agents targeting genome stability for the treatment of cancer (01.09.2019 - 31.12.2021)
- Ottmann, Oliver
An investigation into the effects that CBD has in two TSC cell lines, alone and in combination with rapamycin (12.08.2018 - 30.09.2022)
- Tee, Andrew
Annual Jonathan Boulter Memorial Lecture 2017, Prof NH Ruddle (01.10.2017 - 31.01.2018)
- Caucheteux, Stephane
An observational cross-sectional study to describe the patient profile and secondary care management pathways for patients with hidradenitus in the UK (01.07.2015 - 31.07.2016)
- Ingram, John
-
- Robertson, Neil
An open label, 3-arm, randomised phase 2 study to compare the safety and efficacy of ponatinib in combination with either chemotherapy or blinatumomab (01.01.2019 - 30.06.2024)
- Ottmann, Oliver
An open-label extension study to evaluate the long-term safety and tolerability of intrathecally administered R07234292 (RG6042) in patients with Huntington's disease (BN40955) (01.10.2019 - 31.03.2023)
- Rosser, Anne
An open-label extension study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of ISIS 443139 in Huntington's Disease patients who participated in prior investigational studies of ISIS 443139 (17.04.2018 - 30.04.2020)
- Rosser, Anne
An open label extension study to investigate the long term safety, tolerability and efficacy of PF-02545920 in subjects with Huntington's disease who previously completed study A8241021 (01.10.2015 - 31.12.2017)
- Rosser, Anne
An open label, multicentre phase 1 study to characterize the safety, tolerability, preliminary anti tumour activity, PK and MTD of Bayer 125152 in patients with advanced haematological malignancies (15.12.2016 - 15.11.2018)
- Ottmann, Oliver
An open label, multicentre, randomised, 3-arm study to investigate the comparative efficacy and safety of intravenous ferric carboxymaltose (01.01.2014 - 31.03.2014)
- Riley, Stephen
An open prospective randomised multi-centre clinical evaluation to compare ALLEVYN gentle border with Mepilex border in the management of exuding chronic and acute wounds (22.04.2009 - 21.04.2011)
- Harding, Keith
An open randomised comparative study to evaluate the performance of aquacel extra in venous leg ulcers (01.04.2012 - 31.10.2012)
- Harding, Keith
A novel method to investigate the role of IGF-1 in the responses of human bone to mechanical loading (01.12.2015 - 30.06.2016)
- Scully, Nicole
A novel peer-support intervention using motivational interviewing for breastfeeding maintenance: A UK feasibility study (01.09.2014 - 31.01.2017)
- Paranjothy, Shantini
A novel peer-support intervention using motivational interviewing for breastfeeding maintenance: A UK feasibility study - Excess Treatment Costs (01.07.2015 - 31.03.2016)
- Paranjothy, Shantini
A novel role for oxidized lipid mediators as effectors of muscle atrophy and weakness in aging (30.09.2022 - 31.05.2027)
- O'Donnell, Valerie
A novel tool for rapid diagnosis of metastic cancer (01.07.2014 - 31.08.2015)
- Weeks, Ian
Anthropometric and metabolic correlates of sympathetic nervous system activity in young women with PCOS (01.08.2012 - 31.07.2013)
- Rees, Aled
Antibiotic duration optimisation for UTI (Optimise UTI) (01.08.2022 - 31.07.2025)
- Gillespie, David
Antibiotic resistance plasmids and their contribution to bacterial fitness and virulence (01.10.2009 - 30.09.2012)
- Walsh, Timothy
Antibiotics for lower respiratory tract infections in children presenting in primary care (ARTIC PC) (01.07.2016 - 30.06.2019)
- Francis, Nicholas
Antibiotic treatment and major bleeding in anticoagulant medication users: analysis of health record data to support safer monitoring and prescribing (01.06.2020 - 29.02.2024)
- Ahmed, Haroon
Anti-C7 monoclonal antibody (01.03.2015 - 31.08.2015)
- Morgan, Paul
Antidepressant for the prevention of DEPression following first episode Psychosis trial (ADEPP) (01.11.2019 - 31.12.2023)
- Walters, James
Antigenic ureaplasma variation and adaptation to ovineimmune response following experimental intrarauterin (01.10.2011 - 30.09.2016)
- Spiller, Brad
Anti-microbial peptides (01.12.2007 - 30.11.2008)
- Walsh, Timothy
ANti-psychotic drug Reduction in primary care for adults with learning disabilities (ANDREA-LD): A randomised double-blind placebo controlled trial (01.10.2013 - 31.12.2017)
- Kerr, Michael
Antisense peptide - PNA conjugates as novel antimicrobials for neutralising antibiotic resistance (01.01.2014 - 31.12.2016)
- Walsh, Timothy
Antisocial behaviour in young people with ADHD: Identifying risk pathways (01.03.2011 - 30.11.2013)
- Thapar, Anita
Anti-viral activity of protide derivatives of human T-cells (01.10.2015 - 31.07.2018)
- Piguet, Vincent
Antiviral capacity of surfaces (01.02.2023 - 31.01.2024)
- Stanton, Richard
A open label, multicentre, exploratory phase 2 study in INC424 for patients with primary myelofibrosis or post polycythaemia myelofibrosis or postessential thrombocythaemia myelofibrosis (08.05.2012 - 07.06.2014)
- Knapper, Steven